Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Optical Workings: Specialists Must Communicate to Treat Eye Disease

Richard Quinn  |  May 19, 2017

The intersection of rheumatology and ophthalmology is one in which each specialist needs to truly work well with the other to ensure proper communication and patient care, according to James Rosenbaum, MD, an expert in both fields. Dr. Rosenbaum may be the only rheumatologist in charge of an ophthalmology department. As chair of the Division of Arthritis and Rheumatic Diseases, Oregon Health & Science University, and chief of ophthalmology at Legacy Devers Eye Institute, both in Portland, he understands what he calls the “lacunae in our information” for both fields.

“Ophthalmologists typically don’t know a lot of about immunosuppressive medication, and on the other hand, rheumatologists typically don’t know a lot about eye disease,” Dr. Rosenbaum says. “If two physicians are equally important in the management [of eye disease], I guess it becomes a little bit like two 5-year-olds sharing a toy. Who’s in charge? Who gets what when? Who gets credit? How do you divide the responsibility?”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The answer to each of these rhetorical questions is teamwork, Dr. Rosenbaum says. And although the mantra of teamwork is preached for all situations in which subspecialists co-manage patients, he suggests it is even more important for rheumatologists and ophthalmologists because their skill sets are often vastly different.

“The rheumatologist is impaired in the sense that he or she doesn’t have the instruments to look inside the eye and know whether there is ongoing inflammation,” Dr. Rosenbaum says. “The ophthalmologist is impaired only in the sense of [their] training and approach, so that systemic medications are usually a little bit intimidating.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

One reason for the lack of knowledge on rheumatologists’ part is the change over the past few decades in how physicians are taught to approach physical exams.

“When I started medical school, we had an ophthalmoscope, and we were taught to use the ophthalmoscope. And when we made rounds and worked up a patient in internal medicine, we would do an ophthalmic exam,” Dr. Rosenbaum says. “Now, if you have a patient in the hospital and you want to look for a sign called a ‘Roth spot’ or look in the back of the eye, it’s very hard to ask anyone on the hospital floor to find an ophthalmoscope. They just don’t exist anymore. As technology has gotten better, our imaging has gotten better, our ultrasound and radiology and all kinds of diagnostic tests have gotten better, [but] our skills with the physical exam have disappeared.”

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsOther Rheumatic Conditions Tagged with:eyeEye diseaseInflammatory Eye DiseaseOphthalmologistUveitis

Related Articles

    An Overview of Pediatric, Noninfectious Uveitis

    October 18, 2018

    Uveitis is an inflammation of the uvea, which comprises the iris, ciliary body and choroid. Uveitis can lead to ocular damage and complete visual loss. Noninfectious etiologies for uveitis are the most common in the U.S.1 The estimated incidence of uveitis ranges from 25–52 per 100,000 in adults and five per 100,000 in children. The…

    Watch Those Eyes

    December 1, 2007

    What you need to know about Uveitis in Rheumatic Diseases

    ARZTSAMUI / shutterstock.com

    Uveitis: A Brief Primer for the Rheumatologist

    November 12, 2020

    Uveitis is an umbrella term for intraocular inflammatory diseases that can lead to vision loss. It’s not just a concern for ophthalmologists. Uveitis occurs in approximately 2–5% of patients with inflammatory bowel disease, 6–9% of patients with psoriatic arthritis and 25% of patients with reactive arthritis. The prevalence may be as high as 33% in…

    Stock Footage Inc / shutterstock.com

    ACR, Ophthalmologists & Dermatologists Issue Joint Hydroxychloroquine Statement

    April 17, 2021

    Since 1991, hydroxychloroquine (HCQ) has been a staple for the treatment of patients with systemic lupus erythematosus; it has been shown to improve survival, reduce cardiovascular risk, thrombosis and renal damage, delay or prevent lupus cerebritis and more. However, HCQ can potentially bind in the retinal pigment epithelium and cause degeneration of photoreceptors, leading to…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences